177 related articles for article (PubMed ID: 21229256)
1. Similarities and differences between primary and secondary degeneration of the optic nerve and the effect of minocycline.
Levkovitch-Verbin H; Spierer O; Vander S; Dardik R
Graefes Arch Clin Exp Ophthalmol; 2011 Jun; 249(6):849-57. PubMed ID: 21229256
[TBL] [Abstract][Full Text] [Related]
2. Minocycline mechanism of neuroprotection involves the Bcl-2 gene family in optic nerve transection.
Levkovitch-Verbin H; Waserzoog Y; Vander S; Makarovsky D; Ilia P
Int J Neurosci; 2014 Oct; 124(10):755-61. PubMed ID: 24410139
[TBL] [Abstract][Full Text] [Related]
3. Minocycline upregulates pro-survival genes and downregulates pro-apoptotic genes in experimental glaucoma.
Levkovitch-Verbin H; Waserzoog Y; Vander S; Makarovsky D; Piven I
Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):761-72. PubMed ID: 24566901
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve.
Levkovitch-Verbin H; Dardik R; Vander S; Melamed S
Exp Eye Res; 2010 Aug; 91(2):127-34. PubMed ID: 19951705
[TBL] [Abstract][Full Text] [Related]
5. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Yoles E; Wheeler LA; Schwartz M
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
[TBL] [Abstract][Full Text] [Related]
6. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
[TBL] [Abstract][Full Text] [Related]
7. Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection.
Levkovitch-Verbin H; Kalev-Landoy M; Habot-Wilner Z; Melamed S
Arch Ophthalmol; 2006 Apr; 124(4):520-6. PubMed ID: 16606878
[TBL] [Abstract][Full Text] [Related]
8. The effect of ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model.
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
Acta Ophthalmol; 2010 Aug; 88(5):553-7. PubMed ID: 19681765
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cell death and survival pathways in secondary degeneration of the optic nerve - a long-term study.
Vander S; Levkovitch-Verbin H
Curr Eye Res; 2012 Aug; 37(8):740-8. PubMed ID: 22631427
[TBL] [Abstract][Full Text] [Related]
10. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection.
Levkovitch-Verbin H; Quigley HA; Martin KR; Zack DJ; Pease ME; Valenta DF
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3388-93. PubMed ID: 12882786
[TBL] [Abstract][Full Text] [Related]
11. Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats.
Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK
Exp Eye Res; 2011 Feb; 92(2):112-9. PubMed ID: 21185832
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats.
Tsai RK; Chang CH; Wang HZ
Exp Eye Res; 2008 Sep; 87(3):242-50. PubMed ID: 18602391
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of 4-(Phenylsulfanyl)butan-2-one on optic nerve crush model in rats.
Chien JY; Sheu JH; Wen ZH; Tsai RK; Huang SP
Exp Eye Res; 2016 Feb; 143():148-57. PubMed ID: 26472213
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model.
Thaler S; Fiedorowicz M; Grieb P; Wypych Z; Knap N; Borowik T; Zawada K; Kaminski J; Wozniak M; Rejdak R; Zrenner E; Schuettauf F
Acta Ophthalmol; 2011 Nov; 89(7):e555-60. PubMed ID: 21645284
[TBL] [Abstract][Full Text] [Related]
15. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush.
Jehle T; Dimitriu C; Auer S; Knoth R; Vidal-Sanz M; Gozes I; Lagrèze WA
Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1255-63. PubMed ID: 18414890
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration.
Karim MZ; Sawada A; Mizuno K; Kawakami H; Ishida K; Yamamoto T
J Glaucoma; 2009 Jan; 18(1):26-31. PubMed ID: 19142131
[TBL] [Abstract][Full Text] [Related]
17. A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat.
Maeda K; Sawada A; Matsubara M; Nakai Y; Hara A; Yamamoto T
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):851-6. PubMed ID: 14985301
[TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent.
Tsai RK; Chang CH; Sheu MM; Huang ZL
Exp Eye Res; 2010 May; 90(5):537-45. PubMed ID: 20144610
[TBL] [Abstract][Full Text] [Related]
19. Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy.
Baptiste DC; Powell KJ; Jollimore CA; Hamilton C; LeVatte TL; Archibald ML; Chauhan BC; Robertson GS; Kelly ME
Neuroscience; 2005; 134(2):575-82. PubMed ID: 15939545
[TBL] [Abstract][Full Text] [Related]
20. Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat.
Blair M; Pease ME; Hammond J; Valenta D; Kielczewski J; Levkovitch-Verbin H; Quigley H
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):884-90. PubMed ID: 15728544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
